INSP: Kirby McInerney LLP Advises Inspire Medical Systems, Inc. Investors of Class Action Lawsuit

Core Viewpoint - The lawsuit against Inspire Medical Systems, Inc. alleges that the company made false statements regarding the demand and launch of its implantable medical device for obstructive sleep apnea, leading to significant investor losses [3][4]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of investors who purchased Inspire securities from August 6, 2024, to August 4, 2025, alleging misleading statements and failure to disclose poor demand and inventory issues [3]. - The lawsuit claims that Inspire Medical failed to complete essential tasks for a successful product launch, contrary to the company's assurances to investors [3]. Group 2: Impact of Company Disclosure - On August 4, 2025, Inspire disclosed that the launch of Inspire V was delayed due to incomplete training and onboarding at treatment centers, which affected the ability to bill for procedures [4]. - The company admitted to poor demand for Inspire V, resulting in a reduction of its 2025 earnings guidance by over 80%, causing a significant drop in share price from $129.95 to $87.91, a decline of approximately 32.35% [4].